Stephen F. Betz, Chief Scientific Officer: Crinetics Pharmaceuticals CRNX Sell · Filed 03/18

Trade details

Type: Insider sale
Amount: $236,427.81
Shares · price: 6,371 sh · $37.11 a share
Held after: 141,342 sh
Stock: Crinetics Pharmaceuticals CRNX
Person: Stephen F. BetzChief Scientific Officer
Trade date: 26/03/16
Filed: 26/03/18
Days to filing: 2 days

Sold 4.3% of holdings

Share of holding sold: 4.3%

Crinetics Pharmaceuticals trades, last 26 weeks

What else happened in Crinetics Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/14~04/15

Stephen F. Betz's recent trades

Stephen F. BetzChief Scientific Officer
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$160.2K
4,241 sh
$160.2K
Filed 03/18
Traded 03/16
Stephen F. BetzChief Scientific Officer
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$3.1M
97,483 sh
$3.1M
Filed 25/06/16
Traded 25/06/12
Stephen F. BetzChief Scientific Officer
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$187.2K
5,479 sh
$187.2K
Filed 25/03/21
Traded 25/03/19
Stephen F. BetzChief Scientific Officer
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$10.1K
291 sh
$10.1K
Filed 25/03/21
Traded 25/03/19
Stephen F. BetzChief Scientific Officer
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$53.3K
1,035 sh
$53.3K
Filed 24/09/12
Traded 24/09/10

Stephen F. Betz, Chief Officer — sold $236.4K of Crinetics Pharmaceuticals CRNX · 4.3% of holdings · 10b5-1 plan | Whalegun